IPHA Innate Pharma S.A.
Healthcare$1.72-6.01%ClosedMarket Cap: $161.5M
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$3.50
Target (Median)
$3.50
Target Range
$2.00 - $5.00
Upside from current price: 103.5%
Rating Distribution
0 Strong Buy3 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-04-07 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-10-29 | HC Wainwright & Co. | upgrade | Buy | Neutral |
| 2025-10-29 | BTIG | maintain | Buy | Buy |
| 2025-09-18 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2025-09-18 | Leerink Partners | downgrade | Market Perform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-0.45 | $36.9M | 2 |
| Fri Dec 31 | $0.04 | $63.8M | 2 |
| Sun Dec 31 | $-0.41 | $40.7M | 1 |
| Mon Dec 31 | $0.34 | $190.0M | 1 |